tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
US Market

Apellis Pharmaceuticals (APLS) Income Statement

Compare
868 Followers

Apellis Pharmaceuticals Income Statement

Last quarter (Q3 2024), Apellis Pharmaceuticals's total revenue was $196.83M, an increase of 98.45% from the same quarter last year. In Q3, Apellis Pharmaceuticals's net income was $-57.45M. See Apellis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 396.59M$ 75.42M$ 66.56M$ 250.65M$ 0.00
Gross Profit
$ 338.08M$ 69.79M$ 61.36M$ 225.60M$ -288.02M
Operating Expenses
$ 855.20M$ 664.40M$ 597.64M$ 439.32M$ 288.02M
Depreciation and Amortization
$ 1.70M$ 1.49M$ 1.49M$ 859.00K$ 595.45K
EBITDA
$ -495.21M$ -617.39M$ -731.27M$ -312.23M$ -298.83M
Operating Income
$ -517.12M$ -594.61M$ -536.28M$ -213.73M$ -288.02M
Other Income/Expenses
$ -9.38M$ -56.89M$ -209.72M$ -129.30M$ -16.69M
Pretax Income
$ -526.50M$ -651.50M$ -746.00M$ -343.03M$ -304.71M
Net Income
$ -528.63M$ -652.17M$ -746.35M$ -344.87M$ -309.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.45$ -6.15$ -8.84$ -4.59$ -4.98
Diluted EPS
$ -4.45$ -6.15$ -8.84$ -4.59$ -4.98
Weighted Average Shares Outstanding
118.68M 106.11M 84.42M 75.16M 62.23M
Weighted Average Shares Outstanding (Diluted)
118.68M 106.11M 84.42M 75.16M 62.23M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis